Parliament Workbench
Data: Motions & questions to 19 Nov 2026

Written Question · S3W-04287 · Session 3

Whether it supports the acquisition of Alba Biosciences by Quotient BioResearch.

Answered Asked by Jeremy Purvis LD Lodged 12 Sep 2007

The question

To ask the Scottish Executive whether it supports the acquisition of Alba Biosciences by Quotient BioResearch.

The answer

Answered by Nicola Sturgeon on 20 Sep 2007 · 8 days after it was lodged, on time

The majority of AlbaBiosciences business and income, over a number of years, has been derived from overseasmarkets outside the NHS. It was not, therefore appropriate to retain Alba Bioscienceas part of NHS Scotland, with responsibility for investment and associated risksinvolved.
The sale will haveno impact on the provision of medical products used in the treatment of patients.There are a number of alternative suppliers of the products that NHS Scotland requires,which will continue to be procured under existing arrangements in the same way thatmost modern pharmaceutical products are bought by the NHS.
The sale has providedstability for the vast majority of staff, who have transferred to Quotient BioResearch.This will retain the skills of the workforce and will provide opportunities forthe further growth and development of a Scottish-based business.

In the Official Report

No contribution in the Official Report cites S3W-04287 by reference.